Cargando…

Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine

The endocannabinoid system exerts an important role in pain processing and modulation. Modulation of the system with hydrolase inhibitors of anandamide (AEA) or 2-arachidonyl glycerol (2-AG) has proved effective in reducing migraine-like features in animal models of migraine. Here, we investigated t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greco, Rosaria, Demartini, Chiara, Francavilla, Miriam, Zanaboni, Anna Maria, Tassorelli, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534238/ https://www.ncbi.nlm.nih.gov/pubmed/34685523 http://dx.doi.org/10.3390/cells10102543

Ejemplares similares

Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Antagonism of CGRP Receptor: Central and Peripheral Mechanisms and Mediators in an Animal Model of Chronic Migraine
por: Greco, Rosaria, et al.
Publicado: (2022)

Endocannabinoid System and Migraine Pain: An Update
por: Greco, Rosaria, et al.
Publicado: (2018)

The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model
por: Demartini, Chiara, et al.
Publicado: (2017)

Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain
por: Della Pietra, Adriana, et al.
Publicado: (2023)

Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings
por: Demartini, Chiara, et al.
Publicado: (2023)

Modulation of Glia Activation by TRPA1 Antagonism in Preclinical Models of Migraine
por: Demartini, Chiara, et al.
Publicado: (2022)

Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Hexafluoroisopropyl Carbamates as Selective MAGL and Dual MAGL/FAAH Inhibitors: Biochemical and Physicochemical Properties
por: Barth, Maximilian, et al.
Publicado: (2022)

Correction: Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine
por: Greco, Rosaria, et al.
Publicado: (2022)

Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine?
por: Greco, Rosaria, et al.
Publicado: (2020)

Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine
por: Greco, Rosaria, et al.
Publicado: (2015)

Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine
por: Della Pietra, Adriana, et al.
Publicado: (2021)

Oculo-vestibular signs in experimentally induced migraine attacks: an exploratory analysis
por: Corrado, Michele, et al.
Publicado: (2022)

Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing
por: Greco, Rosaria, et al.
Publicado: (2018)

URB937 Prevents the Development of Mechanical Allodynia in Male Rats with Trigeminal Neuralgia
por: Demartini, Chiara, et al.
Publicado: (2023)

Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
por: Bedse, Gaurav, et al.
Publicado: (2018)

Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks
por: De Icco, Roberto, et al.
Publicado: (2021)

Antagonism of Transient Receptor Potential Ankyrin Type-1 Channels as a Potential Target for the Treatment of Trigeminal Neuropathic Pain: Study in an Animal Model
por: Demartini, Chiara, et al.
Publicado: (2018)

Effects of anandamide in migraine: data from an animal model
por: Greco, Rosaria, et al.
Publicado: (2011)

P007. Inhibition of monoacylglycerol lipase activity modulates the activation of brain structures relevant for migraine pathogenesis
por: Greco, Rosaria, et al.
Publicado: (2015)

Effects of URB937 on an animal model of migraine pain
por: Greco, R, et al.
Publicado: (2013)

Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine
por: Andreou, Anna P., et al.
Publicado: (2020)

Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model
por: Greco, Rosaria, et al.
Publicado: (2014)

Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors
por: Ren, Si-yu, et al.
Publicado: (2020)

EHMTI-0141. URB937 as a potential therapeutic option for migraine: evaluation in animal model of migraine
por: Greco, R, et al.
Publicado: (2014)

Weak Hypotensive Effect of Chronic Administration of the Dual FAAH/MAGL Inhibitor JZL195 in Spontaneously Hypertensive Rats as Revealed by Area under the Curve Analysis
por: Toczek, Marek, et al.
Publicado: (2023)

CD163 as a Potential Biomarker of Monocyte Activation in Ischemic Stroke Patients
por: Greco, Rosaria, et al.
Publicado: (2021)

The Grand Challenge in Cranial Pain—From Migraine to Cranial Neuralgias: Understanding Differences and Similarities to Advance Knowledge and Management
por: Tassorelli, Cristina
Publicado: (2017)

Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review
por: Matheson, Justin, et al.
Publicado: (2021)

Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia
por: Sandrini, Giorgio, et al.
Publicado: (2017)

Role of Estrogens in Menstrual Migraine
por: Nappi, Rossella E., et al.
Publicado: (2022)

Eptinezumab for migraine prevention in patients 50 years or older
por: Martin, Vincent, et al.
Publicado: (2022)

The Mechanism of Pain in Migraine
Publicado: (1905)

Pain Perception and Migraine
por: Russo, Antonio, et al.
Publicado: (2018)

Toll-like receptors and their role in neuropathic pain and migraine
por: Liu, Xuejiao, et al.
Publicado: (2022)

Menstrual migraine, migraine and contraceptions, migraine and pregnancy and migraine triggers
por: MacGregor, Anne
Publicado: (2013)

Traumatic Experiences, Stressful Events, and Alexithymia in Chronic Migraine With Medication Overuse
por: Bottiroli, Sara, et al.
Publicado: (2018)

Comorbid pain and migraine chronicity: The Chronic Migraine Epidemiology and Outcomes Study
por: Scher, Ann I., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qu87q2c15rpir8m084mi59n130